These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 30271598

  • 1. Influence of initiation time and white blood cell count on the efficacy of cytotoxic agents in acute promyelocytic leukemia during induction treatment.
    Xu F, Yin CX, Wang CL, Ding BJ, Zhong QX, Jiang XJ, Jiang L, Wang ZX, Meng FY.
    Biomed Rep; 2018 Sep; 9(3):227-232. PubMed ID: 30271598
    [Abstract] [Full Text] [Related]

  • 2. Dynamic changes and multiplication rate of white blood cell count may direct the timing of cytoreduction chemotherapy during induction treatment in newly diagnosed acute promyelocytic leukemia with low-intermediate risk.
    Wen J, Xu F, Zhou Q, Hu H, Liu Y, Su J, Zhang Y, Qu W, Shi L.
    Mol Clin Oncol; 2021 Jun; 14(6):112. PubMed ID: 33903818
    [Abstract] [Full Text] [Related]

  • 3. Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia.
    Wen J, Xu F, Zhou Q, Shi L, Liu Y, Yue J, Zhang Y, Liang X.
    BMC Cancer; 2023 Jan 07; 23(1):27. PubMed ID: 36611025
    [Abstract] [Full Text] [Related]

  • 4. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
    Hu J, Shen ZX, Sun GL, Chen SJ, Wang ZY, Chen Z.
    Int J Hematol; 1999 Dec 07; 70(4):248-60. PubMed ID: 10643151
    [Abstract] [Full Text] [Related]

  • 5. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 Dec 07; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 6. The kinetics of white blood cell and the predictive factors of leukocytosis under oral or intravenous arsenic as the first-line treatment for acute promyelocytic leukemia.
    Wang F, Jia JS, Wang J, Zhao T, Jiang Q, Jiang H, Zhu HH.
    Leuk Res; 2017 Oct 07; 61():84-88. PubMed ID: 28934679
    [Abstract] [Full Text] [Related]

  • 7. Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia.
    Thomas X, Dombret H, Cordonnier C, Pigneux A, Gardin C, Guerci A, Vekhoff A, Sadoun A, Stamatoullas A, Fegueux N, Maloisel F, Cahn JY, Reman O, Gratecos N, Berthou C, Huguet F, Kotoucek P, Travade P, Buzyn A, de Revel T, Vilque JP, Naccache P, Chomienne C, Degos L, Fenaux P.
    Leukemia; 2000 Jun 07; 14(6):1006-13. PubMed ID: 10865965
    [Abstract] [Full Text] [Related]

  • 8. Effect of all-trans-retinoic acid alone or in combination with chemotherapy in newly diagnosed acute promyelocytic leukaemia.
    Colović MD, Janković GM, Elezović I, Vidović A, Bila JS, Novak A, Babić D.
    Med Oncol; 1997 Jun 07; 14(2):65-72. PubMed ID: 9330265
    [Abstract] [Full Text] [Related]

  • 9. [Efficacy analysis of sequential treatment with chemotherapy, ATRA and As(2)O(3) for acute promyelocytic leukemia].
    Ma XJ, Ren HY, Cen XN, Qiu ZX, Wang WS, Ou JP, Wang Y, Xu WL, Li Y, Wang MJ, Wang LH, Dong YJ, Yin Y, Liang ZY.
    Zhonghua Xue Ye Xue Za Zhi; 2010 May 07; 31(5):328-32. PubMed ID: 21122313
    [Abstract] [Full Text] [Related]

  • 10. Reduction of pulmonary toxicity by prednisolone prophylaxis during all-trans retinoic acid treatment of acute promyelocytic leukemia. Australian Leukaemia Study Group.
    Wiley JS, Firkin FC.
    Leukemia; 1995 May 07; 9(5):774-8. PubMed ID: 7769839
    [Abstract] [Full Text] [Related]

  • 11. Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series.
    Tsimberidou AM, Tirado-Gomez M, Andreeff M, O'Brien S, Kantarjian H, Keating M, Lopez-Berestein G, Estey E.
    Leuk Lymphoma; 2006 Jun 07; 47(6):1062-8. PubMed ID: 16840198
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG).
    Asou N, Adachi K, Tamura U, Kanamaru A, Kageyama S, Hiraoka A, Omoto E, Akiyama H, Tsubaki K, Saito K, Kuriyama K, Oh H, Kitano K, Miyawaki S, Takeyama U, Yamada O, Nishikawa K, Takahashi M, Matsuda S, Ohtake H, Ohno R.
    Cancer Chemother Pharmacol; 2001 Aug 07; 48 Suppl 1():S65-71. PubMed ID: 11587370
    [Abstract] [Full Text] [Related]

  • 16. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D, Chelghoum Y, Le QH, Elhamri M, Michallet M, Thomas X.
    Ann Hematol; 2003 Nov 07; 82(11):684-90. PubMed ID: 12928754
    [Abstract] [Full Text] [Related]

  • 17. [Retinoic acid in treating acute promyelocytic leukemia with hyperleukocytosis and its therapeutic strategy].
    Guo XH, Yasen H, Jiang M, Hao JP, Abulaiti D, Chen R.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr 07; 16(2):439-41. PubMed ID: 18426682
    [Abstract] [Full Text] [Related]

  • 18. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
    Zhu HH, Wu DP, Du X, Zhang X, Liu L, Ma J, Shao ZH, Ren HY, Hu JD, Xu KL, Wang JW, Song YP, Fang MY, Li J, Yan XY, Huang XJ.
    Lancet Oncol; 2018 Jul 07; 19(7):871-879. PubMed ID: 29884593
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.